ArticleFrontiers in pharmacology2023

Case report: ALK D1225N missense mutation in lung adenocarcinoma responds to tyrosine kinase inhibitors.

Jianxin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.